Large Cap U.S. Pharma
Spin-off from Pfizer, selling out-of-patent everday generic medicine.
Have a few of these stocks, doing so-so - i’m not holding out to see much growth.
The price has dropped off so much recently, I think they’re now a decent long hold value buy. The company has committed to about a 3% dividend and the current price is about 4x forward earnings. Not many large caps with P/E’s that low.